Frontiers in Pharmacology | Inflammation Pharmacology

Correction

Published on 12 May 2023

Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway

in Inflammation Pharmacology

Zhou Guo
Jiamin Lin
Kai Sun
Jiayou Guo
Xudong Yao
Genchun Wang
Liangcai Hou
Jingting Xu
Jiachao Guo
Fengjing Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199951

2,377 views
4 citations

Original Research

Published on 11 May 2023

RNA-sequencing approach for exploring the protective mechanisms of dexmedetomidine on pancreatic injury in severe acute pancreatitis

in Inflammation Pharmacology

Jiaqi Yao
Bowen Lan
Chi Ma
Yan Liu
Xiaoqi Wu
Kaixuan Feng
Hailong Chen
Qingping Wen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189486

3,360 views
1 citation

Original Research

Published on 10 May 2023

Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology

in Inflammation Pharmacology

Sanjay Pandey
Vandana Anang
Saurabh Singh
Saurabh Seth
Anant Narayan Bhatt
Namita Kalra
Kailash Manda
Ravi Soni
Bal Gangadhar Roy
K. Natarajan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.940129

3,819 views
6 citations

Original Research

Published on 09 May 2023

Modulation of gut microbiota alleviates cerebral ischemia/reperfusion injury in rats by inhibiting M1 polarization of microglia

in Inflammation Pharmacology

Hai-Jun Li
Dan-Qing Li
Yu-Liang Zhang
Xiao-Fei Ding
Hai-Tao Gao
Ya Zhu
Jun Liu
Li-Xia Zhang
Jie Chen
Guang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123387

3,473 views
12 citations

Correction

Published on 09 May 2023

Corrigendum: Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages

in Inflammation Pharmacology

Yen-Chieh Chuang
Shu-Yu Wu
Yu-Chuan Huang
Chung-Kan Peng
Shih-En Tang
Kun-Lun Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1210999

1,067 views

Brief Research Report

Published on 09 May 2023

Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma

in Inflammation Pharmacology

Christian Domingo
Ana Sogo
Enrique Casado
Eva Martínez-Moragón
Marina Blanco-Aparicio
Teresa Carrillo
David Bañas-Conejero
María-Guadalupe Sánchez-Herrero

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1183156

2,047 views
3 citations

Correction

Published on 09 May 2023

Corrigendum: Clostridium butyricum protects against pancreatic and intestinal injury after severe acute pancreatitis via downregulation of MMP9

in Inflammation Pharmacology

Qingqing Yan
Lin Jia
Biyan Wen
Yao Wu
Yanbo Zeng
Qing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1197442

1,263 views

Brief Research Report

Published on 09 May 2023

Continuous IV infusion of anakinra

in Inflammation Pharmacology

Brittney N. Saunders
Marcela V. Kuijpers
Jason J. Sloan
Elie Gertner

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1162742

6,712 views
6 citations

Review

Published on 09 May 2023

Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice

in Inflammation Pharmacology

Akib Nisar
Suresh Jagtap
Suresh Vyavahare
Manasi Deshpande
Abhay Harsulkar
Prabhakar Ranjekar
Om Prakash

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1177050

14,066 views
53 citations

Mini Review

Published on 04 May 2023

One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19

in Inflammation Pharmacology

Yuanyuan Yu
Bangjiang Fang
Xiao-Dong Yang
Yuejuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185076

9,967 views
6 citations

Review

Published on 04 May 2023

Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis

in Inflammation Pharmacology

Ling Li
Jiajun Yu
Baoqing Chen
Ying Guo
Yufeng Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154949

5,712 views
5 citations

Review

Published on 02 May 2023

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease

in Inflammation Pharmacology

Jie Lun
Hongwei Zhang
Jing Guo
Mengchao Yu
Jing Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1045997

4,601 views
7 citations

Original Research

Published on 26 Apr 2023

Flurbiprofen inhibits heme induced NLRP3 inflammasome in Berkeley sickle cell disease mice

in Inflammation Pharmacology

Dilpreet Kour
Mehboob Ali
Parul Khajuria
Kuhu Sharma
Palash Ghosh
Sukhleen Kaur
Surbhi Mahajan
P. Ramajayan
Sonali S. Bharate
Subhash Bhardwaj

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123734

3,627 views
1 citation

Review

Published on 21 Apr 2023

Immunomodulatory biomaterials on chemokine signaling in wound healing

in Inflammation Pharmacology

Anisha Apte
Kenneth W. Liechty
Carlos Zgheib

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1084948

3,980 views
18 citations

Original Research

Published on 21 Apr 2023

P2X7 receptor contributes to long-term neuroinflammation and cognitive impairment in sepsis-surviving mice

in Inflammation Pharmacology

Vinícius Santos Alves
Joyce Pereira da Silva
Fabiana Cristina Rodrigues
Suzana Maria Bernardino Araújo
André Luiz Gouvêa
Raíssa Leite-Aguiar
Stephanie Alexia Cristina Silva Santos
Milla Souza Pessoa da Silva
Fernanda Silva Ferreira
Eduardo Peil Marques

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1179723

4,661 views
11 citations

Original Research

Published on 20 Apr 2023

N-benzyl-N-methyldecan-1-amine and its derivative mitigate 2,4- dinitrobenzenesulfonic acid-induced colitis and collagen-induced rheumatoid arthritis

in Inflammation Pharmacology

Ji Eun Kim
Changyu Kang
Phatcharaporn Budluang
Natpaphan Yawut
Il-Rae Cho
Yun Ju Choi
Jaejeong Kim
Sanghyun Ju
Beomgu Lee
Dong Hyun Sohn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1095955

4,331 views
4 citations